Table 1.
Variable Mean (∓SD) | Ketamine | Midazolam | Statistics (df),p |
---|---|---|---|
Gender (M/F) | 10/4 | 7/6 | Χ2(1) = 0.16, p = n.s |
Age | 40.7 (∓10.7) | 35.1 (∓10.34) | t(24) = 1.35, p = n.s |
Race/Ethnicity | Black - 1 | Black - 1 | Χ2(5) = 3.04, p = n.s |
Hispanic - 2 | Hispanic - 0 | ||
American Indian - 0 | American Indian - 1 | ||
Asian - 0 | Asian - 1 | ||
Hawaiian - 1 | Hawaiian - 0 | ||
White - 11 | White - 10 | ||
Unknown - 1 | Unknown -1 | ||
PCL-5 Before Treatment | 48.8 (∓12.3) | 44.4 (∓14.4) | t(25) = 0.85, p = n.s |
PCL-5 At End of Treatment | 29.5 (∓20.7) | 35.1 (∓16.8) | t(25) = −0.76, p = n.s |
PCL-5 Follow-up | 32.7 (∓14.95) | 28.1 (∓18.1) | t(21) = 0.66, p = n.s |
BDI-II Before Treatment | 24.4 (∓9.2) | 24.6 (∓12.3) | t(24) = −0.05, p = n.s. |
BDI-II At End of Treatment | 16.5 (∓12.9) | 17.1 (∓10.7) | t(25) = −0.12, p = n.s. |
BDI-II Follow-up | 20.9 (∓12.2) | 14.5 (∓11.1) | t(22) = 1.4, p = n.s. |
Time from Criteria A Trauma (years) | 12.11 (∓8.62) | 13.88 (∓11.18) | t(23) = −0.45, p = n.s |
Lifetime Substance Use/Dependence (yes/no) |
7/7 | 6/7 | Χ2(1) = 1, p = n.s |
Current MDD Episode | 13/13 | 8/11 | Χ2(1) = 1.94, p = n.s |
Trauma Type | |||
Combat | 4 | 0 | |
Violence | 3 | 2 | |
Sexual | 3 | 4 | |
Other | 3 | 5 |